Genistein significantly reduces the methylation levels of the BTG3 promoter and promotes histone H3 and H4 acetylation, which reactivates BTG3 expression, induces G1-phase cell cycle arrest, inhibits RCC cell proliferation, and promotes apoptosis [46]. The gene discussed is BTG3; the disease is renal cell carcinoma.